Motor Neurone Disease Trial, Recruiting NCT05116943 Sponsor: Mayo Clinic Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT05116943
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with ALS, ALS-FTD, or a similar neurodegenerative disease:

  • People who have received a formal diagnosis of ALS (at any level of certainty, based on established diagnostic guidelines) or a similar neurodegenerative disease.
  • People who are willing to give their consent to participate, or to give assent if muscle weakness caused by their disease makes signing consent difficult.

Spouses/domestic partners of people with ALS/ALS-FTD, or people with a family history of ALS/ALS-FTD or a similar disease:

  • People who have never personally had ALS, ALS-FTD, or any other motor neuron disease.
  • People whose family history of ALS or ALS-FTD involves a relative who is a first, second, or third degree blood relative (such as a parent, sibling, grandparent, aunt, uncle, or cousin).
  • People who are willing to give their consent to participate.

Who may not be able to join:

People with ALS, ALS-FTD, or a similar neurodegenerative disease:

  • People who have another medical condition that makes it unclear whether their neurological symptoms are caused by a neurodegenerative disease or something else entirely.
  • People whose cognitive or mental capacity would prevent them from safely cooperating with a spinal fluid sample (lumbar puncture) or a standard blood draw.
  • People who have a higher-than-normal risk of bleeding complications, or who have an allergy to the local anaesthetic or skin-cleaning solution used during a lumbar puncture.

Spouses/domestic partners or people with a family history of ALS/ALS-FTD:

  • People whose cognitive or mental capacity would prevent them from safely cooperating with a lumbar puncture or a standard blood draw.
  • People who have a higher-than-normal risk of bleeding complications, or who have an allergy to the local anaesthetic or skin-cleaning solution used during a lumbar puncture.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
19 August 2013
Est. completion
1 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Blood serum collection; Blood plasma collection; Cerebrospinal fluid collection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov